




Searching News Database: arthritis
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 31 Jan 2025
U.S. FDA Approves Celltrion's AVTOZMA(R) (tocilizumab-anoh), a Biosimilar to ACTEMRA(R)
U.S. FDA Approves Celltrion's AVTOZMA(R) (tocilizumab-anoh), a Biosimilar to ACTEMRA(R)
HSMN NewsFeed - 22 Jan 2025
Shotel(TM) Medical Expansion Signals Growing Demand for Its Ankle Arthrodesis Device
Shotel(TM) Medical Expansion Signals Growing Demand for Its Ankle Arthrodesis Device
HSMN NewsFeed - 14 May 2024
Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
Brixton Biosciences Announces $33M in Series B Funding to Advance Novel Technology for the Treatment of Pain
HSMN NewsFeed - 31 Oct 2023
Ortho Development(R) Announces Launch of the BKS(R) Uni Partial Knee System
Ortho Development(R) Announces Launch of the BKS(R) Uni Partial Knee System
HSMN NewsFeed - 4 Oct 2023
U.S. FDA Grants Lipogems(R) Second IDE Approval for a Clinical Trial on the Treatment for Knee OA
U.S. FDA Grants Lipogems(R) Second IDE Approval for a Clinical Trial on the Treatment for Knee OA
HSMN NewsFeed - 14 Apr 2022
NCCN Guidelines(R) Recommend VONJO(TM) (pacritinib) for the Treatment of Myeloproliferative Neoplasms
NCCN Guidelines(R) Recommend VONJO(TM) (pacritinib) for the Treatment of Myeloproliferative Neoplasms
HSMN NewsFeed - 11 Apr 2022
CMS grants outpatient facility code for insertion of Stryker's InSpace subacromial balloon spacer
CMS grants outpatient facility code for insertion of Stryker's InSpace subacromial balloon spacer
HSMN NewsFeed - 30 Mar 2022
FDA approves CartiHeal's Implant for the Treatment of Cartilage and Osteochondral Defects
FDA approves CartiHeal's Implant for the Treatment of Cartilage and Osteochondral Defects
HSMN NewsFeed - 4 Jun 2021
Ortho Regenerative Technologies Receives Clinical Hold Letter From the U.S. FDA
Ortho Regenerative Technologies Receives Clinical Hold Letter From the U.S. FDA
HSMN NewsFeed - 28 Apr 2021
Roam Robotics Announces Ascend Smart Knee, Pioneering a New Era of Human Mobility
Roam Robotics Announces Ascend Smart Knee, Pioneering a New Era of Human Mobility
HSMN NewsFeed - 20 Apr 2021
Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study
Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study
HSMN NewsFeed - 16 Feb 2021
Akan Biosciences Announces FDA Acceptance of IND Application for StroMel(TM) in Osteoarthritis of Knee
Akan Biosciences Announces FDA Acceptance of IND Application for StroMel(TM) in Osteoarthritis of Knee
HSMN NewsFeed - 5 Jan 2021
Ortho Regenerative Technologies Enters Into Global License With Hanuman Pelican, Inc.
Ortho Regenerative Technologies Enters Into Global License With Hanuman Pelican, Inc.
HSMN NewsFeed - 22 Dec 2020
Update On SOURCE Phase 3 Trial For Tezepelumab In Patients With Severe, Oral Corticosteroid-Dependent Asthma
Update On SOURCE Phase 3 Trial For Tezepelumab In Patients With Severe, Oral Corticosteroid-Dependent Asthma
HSMN NewsFeed - 17 Dec 2020
FDA Approves GSK's BENLYSTA as the First Medicine for Adult Patients with Active Lupus Nephritis in the US
FDA Approves GSK's BENLYSTA as the First Medicine for Adult Patients with Active Lupus Nephritis in the US
HSMN NewsFeed - 10 Dec 2020
Rani Therapeutics Raises $69 Million Series E To Advance Clinical Trials And Manufacturing Of Robotic Pill
Rani Therapeutics Raises $69 Million Series E To Advance Clinical Trials And Manufacturing Of Robotic Pill
HSMN NewsFeed - 19 Oct 2020
Solarea Bio Announces Series A Financing Led by S2G Ventures and Bold Capital Partners
Solarea Bio Announces Series A Financing Led by S2G Ventures and Bold Capital Partners
HSMN NewsFeed - 12 Oct 2020
CartiHeal Receives FDA "Breakthrough Device Designation" for the novel Agili-C Implant
CartiHeal Receives FDA "Breakthrough Device Designation" for the novel Agili-C Implant
HSMN NewsFeed - 3 Sep 2020
Innovent Announces NMPA Granted Marketing Approval for SULINNO(R) (Adalimumab Injection) in China
Innovent Announces NMPA Granted Marketing Approval for SULINNO(R) (Adalimumab Injection) in China
HSMN NewsFeed - 2 Sep 2020
Smith & Nephew launches NOVOSTITCH(TM) PRO Meniscal Repair System in Europe
Smith & Nephew launches NOVOSTITCH(TM) PRO Meniscal Repair System in Europe
HSMN NewsFeed - 10 Aug 2020
NBE-Therapeutics Appoints Erich Schlick as Chairman of the Board of Directors
NBE-Therapeutics Appoints Erich Schlick as Chairman of the Board of Directors
HSMN NewsFeed - 24 Jul 2020
Bimekizumab Superior to Cosentyx(R) in Achieving Complete Psoriasis Skin Clearance
Bimekizumab Superior to Cosentyx(R) in Achieving Complete Psoriasis Skin Clearance
HSMN NewsFeed - 4 Jun 2020
Mylan and Lupin Receive European Marketing Authorization for Nepexto(R), Biosimilar Etanercept
Mylan and Lupin Receive European Marketing Authorization for Nepexto(R), Biosimilar Etanercept
HSMN NewsFeed - 27 May 2020
Acquist Therapeutics Announces New Appointments to its Board of Directors
Acquist Therapeutics Announces New Appointments to its Board of Directors
HSMN NewsFeed - 6 Apr 2020
Perrigo Announces FDA Approval for the Store Brand Equivalent of Voltaren(R) Arthritis Pain
Perrigo Announces FDA Approval for the Store Brand Equivalent of Voltaren(R) Arthritis Pain
HSMN NewsFeed - 16 Mar 2020
Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for the Treatment of Alopecia Areata
Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for the Treatment of Alopecia Areata
HSMN NewsFeed - 13 Mar 2020
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
HSMN NewsFeed - 12 Feb 2020
Regenexx, First to Use Stem Cells in Orthopedic Therapy, Marks 15th Anniversary
Regenexx, First to Use Stem Cells in Orthopedic Therapy, Marks 15th Anniversary
HSMN NewsFeed - 2 Dec 2019
Cumberland Pharmaceuticals Receives FDA Approval for RediTrex(TM) Product Line
Cumberland Pharmaceuticals Receives FDA Approval for RediTrex(TM) Product Line
HSMN NewsFeed - 10 Oct 2019
FDA Grants Ofev(R) Breakthrough Therapy Designation for Chronic Fibrosing ILDs with a Progressive Phenotype
FDA Grants Ofev(R) Breakthrough Therapy Designation for Chronic Fibrosing ILDs with a Progressive Phenotype
HSMN NewsFeed - 5 Jun 2019
FDA Premarket Approval Granted for DT MedTech's Hintermann Series H3(TM) Total Ankle Replacement System
FDA Premarket Approval Granted for DT MedTech's Hintermann Series H3(TM) Total Ankle Replacement System
HSMN NewsFeed - 14 May 2019
Boehringer Ingelheim announces resolution of Cyltezo(R) patent litigation
Boehringer Ingelheim announces resolution of Cyltezo(R) patent litigation
HSMN NewsFeed - 29 Apr 2019
First Patient in New England Treated With the Agili-C(TM) Implant at CartiHeal's Pivotal Study
First Patient in New England Treated With the Agili-C(TM) Implant at CartiHeal's Pivotal Study
HSMN NewsFeed - 28 Mar 2019
Hyalex Orthopaedics, synthetic cartilage company, adds new funding; expanding Series A total to $33MM
Hyalex Orthopaedics, synthetic cartilage company, adds new funding; expanding Series A total to $33MM
HSMN NewsFeed - 13 Mar 2019
Alvotech Enrolls First Patient in Clinical Phase III Study Involving Biosimilar Version of HUMIRA(R)
Alvotech Enrolls First Patient in Clinical Phase III Study Involving Biosimilar Version of HUMIRA(R)
HSMN NewsFeed - 19 Feb 2019
Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain
Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain
HSMN NewsFeed - 28 Nov 2018
Generex Biotechnology Expands Medical Device Portfolio With Acquisition of Olaregen Therapeutix Inc.
Generex Biotechnology Expands Medical Device Portfolio With Acquisition of Olaregen Therapeutix Inc.
HSMN NewsFeed - 5 Nov 2018
Shoulder Innovations Announces FDA 510(k) Clearance For Shoulder Technology
Shoulder Innovations Announces FDA 510(k) Clearance For Shoulder Technology
HSMN NewsFeed - 15 Oct 2018
Medivir to Focus on its Clinical Development and Appoints Uli Hacksell as Acting CEO
Medivir to Focus on its Clinical Development and Appoints Uli Hacksell as Acting CEO
HSMN NewsFeed - 24 Sep 2018
Cumberland Pharmaceuticals Announces Senior Music Industry Executive Joins Its Board Of Directors
Cumberland Pharmaceuticals Announces Senior Music Industry Executive Joins Its Board Of Directors
HSMN NewsFeed - 17 Sep 2018
CartiHeal Performs First Hungarian Case in the Agili-C(TM) Implant IDE Multinational Pivotal Study
CartiHeal Performs First Hungarian Case in the Agili-C(TM) Implant IDE Multinational Pivotal Study
HSMN NewsFeed - 14 Aug 2018
Inova Diagnostics Receives FDA Clearance for Test to Detect Antibodies to HMGCR
Inova Diagnostics Receives FDA Clearance for Test to Detect Antibodies to HMGCR
HSMN NewsFeed - 28 Jun 2018
Lupin and Mylan Partner to Commercialize Enbrel(R) (Etanercept) Biosimilar
Lupin and Mylan Partner to Commercialize Enbrel(R) (Etanercept) Biosimilar
HSMN NewsFeed - 18 Jun 2018
Mallinckrodt Reports Interim Findings Of H.P. Acthar(R) Gel (Repository Corticotropin Injection) Studies
Mallinckrodt Reports Interim Findings Of H.P. Acthar(R) Gel (Repository Corticotropin Injection) Studies
HSMN NewsFeed - 8 Jun 2018
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
HSMN NewsFeed - 14 May 2018
CurveBeam Announces FDA 510(k) Clearance for LineUP Weight Bearing Multi-Extremity CT System
CurveBeam Announces FDA 510(k) Clearance for LineUP Weight Bearing Multi-Extremity CT System
HSMN NewsFeed - 7 Mar 2018
New Blood Test to Accurately Detect Fibromyalgia Now Available from Data Science Company IQuity
New Blood Test to Accurately Detect Fibromyalgia Now Available from Data Science Company IQuity
HSMN NewsFeed - 7 Feb 2018
UNITY Biotechnology Adds Accomplished R&D Leader David L. Lacey, M.D., to Board of Directors
UNITY Biotechnology Adds Accomplished R&D Leader David L. Lacey, M.D., to Board of Directors
HSMN NewsFeed - 22 Jan 2018
Symic Bio Appoints Hicham Alaoui, Ph.D., as Senior Vice President of Discovery Biology
Symic Bio Appoints Hicham Alaoui, Ph.D., as Senior Vice President of Discovery Biology
HSMN NewsFeed - 22 Jan 2018
AVACEN Medical Device for Autistic Spectrum Disorder Behavior Management Launched in Hong Kong
AVACEN Medical Device for Autistic Spectrum Disorder Behavior Management Launched in Hong Kong
HSMN NewsFeed - 5 Dec 2017
Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board
Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board
HSMN NewsFeed - 17 Nov 2017
MiMedx Market Leadership Well Positioned In Light Of FDA New Guidance Document
MiMedx Market Leadership Well Positioned In Light Of FDA New Guidance Document
HSMN NewsFeed - 10 Nov 2017
Elanco, Aratana Announce Positive Opinion on GALLIPRANT(R) (grapiprant tablets) in Europe
Elanco, Aratana Announce Positive Opinion on GALLIPRANT(R) (grapiprant tablets) in Europe
HSMN NewsFeed - 3 Nov 2017
Symic Bio Appoints Wayne Froland, Ph.D., as Executive Vice President of Technical Operations
Symic Bio Appoints Wayne Froland, Ph.D., as Executive Vice President of Technical Operations
HSMN NewsFeed - 20 Oct 2017
Celgene Provides Update on GED-0301 (mongersen) Inflammatory Bowel Disease Program
Celgene Provides Update on GED-0301 (mongersen) Inflammatory Bowel Disease Program
HSMN NewsFeed - 3 Oct 2017
Dr. Gloria Matthews Joins MiMedx As Its Senior Vice President Of Research And Development
Dr. Gloria Matthews Joins MiMedx As Its Senior Vice President Of Research And Development
HSMN NewsFeed - 25 Sep 2017
Cumberland Pharmaceuticals Launches Promotion of Totect(R) in The U.S. for Emergency Oncology Intervention
Cumberland Pharmaceuticals Launches Promotion of Totect(R) in The U.S. for Emergency Oncology Intervention
HSMN NewsFeed - 21 Sep 2017
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
HSMN NewsFeed - 21 Jul 2017
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
HSMN NewsFeed - 11 Jul 2017
MedShape Launches the DynaFrame CF Deployment System for TTC Fusion Surgery
MedShape Launches the DynaFrame CF Deployment System for TTC Fusion Surgery
HSMN NewsFeed - 31 May 2017
Hyalex Orthopaedics Raises $16 Million Series A Financing and Appoints Chief Executive Officer
Hyalex Orthopaedics Raises $16 Million Series A Financing and Appoints Chief Executive Officer
HSMN NewsFeed - 15 May 2017
Nuvo Pharmaceuticals(TM) Inc. Announces Topline Results from European Ankle Sprain Study with Pennsaid(R) 2%
Nuvo Pharmaceuticals(TM) Inc. Announces Topline Results from European Ankle Sprain Study with Pennsaid(R) 2%
HSMN NewsFeed - 9 May 2017
FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Cancer
FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Cancer
HSMN NewsFeed - 8 May 2017
Regeneron and Inovio Enter Immuno-Oncology Clinical Study Agreement for Glioblastoma Combination Therapy
Regeneron and Inovio Enter Immuno-Oncology Clinical Study Agreement for Glioblastoma Combination Therapy
HSMN NewsFeed - 26 Apr 2017
FDA Approves XATMEP(TM), the First and Only Ready-To-Use Methotrexate Oral Solution
FDA Approves XATMEP(TM), the First and Only Ready-To-Use Methotrexate Oral Solution
HSMN NewsFeed - 20 Apr 2017
FDA Clears Halyard Health's COOLIEF for the Management of Osteoarthritis Knee Pain
FDA Clears Halyard Health's COOLIEF for the Management of Osteoarthritis Knee Pain
HSMN NewsFeed - 7 Apr 2017
Flexion Therapeutics Announces Appointment of Yamo Deniz, MD, as Chief Medical Officer
Flexion Therapeutics Announces Appointment of Yamo Deniz, MD, as Chief Medical Officer
HSMN NewsFeed - 21 Mar 2017
Forty Seven Inc. Announces Mark McCamish, M.D., Ph.D., to Join as CEO on May 1st
Forty Seven Inc. Announces Mark McCamish, M.D., Ph.D., to Join as CEO on May 1st
HSMN NewsFeed - 16 Mar 2017
Sonoma Pharmaceuticals Announces Results from SebuDerm(TM) Gel Study in Treatment of Seborrheic Dermatitis
Sonoma Pharmaceuticals Announces Results from SebuDerm(TM) Gel Study in Treatment of Seborrheic Dermatitis
HSMN NewsFeed - 9 Feb 2017
Appeals Court Grants Stay of Permanent Injunction for Praluent(R) (alirocumab) During Appeals Process
Appeals Court Grants Stay of Permanent Injunction for Praluent(R) (alirocumab) During Appeals Process
HSMN NewsFeed - 18 Jan 2017
Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid
Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid
HSMN NewsFeed - 4 Jan 2017
Regeneron Hires Jay Markowitz, M.D., as Senior Vice President of Portfolio Management
Regeneron Hires Jay Markowitz, M.D., as Senior Vice President of Portfolio Management
HSMN NewsFeed - 29 Nov 2016
Moximed: First Patient Treated in US Study of Atlas(R) System for Unicompartmental Knee Osteoarthritis
Moximed: First Patient Treated in US Study of Atlas(R) System for Unicompartmental Knee Osteoarthritis
HSMN NewsFeed - 16 Nov 2016
Cumberland Pharmaceuticals Acquires U.S. Rights to Nordic Group's Methotrexate Injection Products
Cumberland Pharmaceuticals Acquires U.S. Rights to Nordic Group's Methotrexate Injection Products
HSMN NewsFeed - 14 Nov 2016
First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar(R) Gel for Rheumatoid Arthritis
First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar(R) Gel for Rheumatoid Arthritis
HSMN NewsFeed - 31 Oct 2016
Antares Pharma Appoints Fred M. Powell, Senior Vice President and Chief Financial Officer
Antares Pharma Appoints Fred M. Powell, Senior Vice President and Chief Financial Officer
HSMN NewsFeed - 12 Sep 2016
Regeneron Announces Election of Bonnie Bassler, Ph.D., and Huda Zoghbi, M.D., to Board of Directors
Regeneron Announces Election of Bonnie Bassler, Ph.D., and Huda Zoghbi, M.D., to Board of Directors
HSMN NewsFeed - 18 Aug 2016
FDA Grants Soligenix Orphan Drug Designation for Dusquetide for Treatment of Macrophage Activation Syndrome
FDA Grants Soligenix Orphan Drug Designation for Dusquetide for Treatment of Macrophage Activation Syndrome
HSMN NewsFeed - 25 Jul 2016
MiMedx Announces Nationwide Launch of New Ambient Temperature Version of OrthoFlo
MiMedx Announces Nationwide Launch of New Ambient Temperature Version of OrthoFlo
HSMN NewsFeed - 13 Jul 2016
Decibel Therapeutics Appoints Steven H. Holtzman as President and Chief Executive Officer
Decibel Therapeutics Appoints Steven H. Holtzman as President and Chief Executive Officer
HSMN NewsFeed - 30 May 2016
FLIXABI(R), Biogen’s Infliximab Biosimilar Referencing Remicade(R), Approved in the European Union
FLIXABI(R), Biogen’s Infliximab Biosimilar Referencing Remicade(R), Approved in the European Union
HSMN NewsFeed - 25 May 2016
Ceterix Announces Appointment of Edward Graubart as Vice President, Sales
Ceterix Announces Appointment of Edward Graubart as Vice President, Sales
HSMN NewsFeed - 4 Apr 2016
Nuvo Pharmaceuticals(TM) Inc. Announces Appointment of Vice President, Business Development
Nuvo Pharmaceuticals(TM) Inc. Announces Appointment of Vice President, Business Development
HSMN NewsFeed - 21 Mar 2016
LEO Pharma Receives Scientific Approval of Enstilar(R) for the Treatment of Psoriasis in EU
LEO Pharma Receives Scientific Approval of Enstilar(R) for the Treatment of Psoriasis in EU
HSMN NewsFeed - 16 Feb 2016
VIVLODEX(TM) Now Available in U.S. Pharmacies for the Management of Osteoarthritis Pain
VIVLODEX(TM) Now Available in U.S. Pharmacies for the Management of Osteoarthritis Pain
HSMN NewsFeed - 17 Jan 2016
BENEPALI(R), the First Etanercept Biosimilar Referencing Enbrel(R), Approved in the European Union
BENEPALI(R), the First Etanercept Biosimilar Referencing Enbrel(R), Approved in the European Union
HSMN NewsFeed - 13 Jan 2016
Galapagos and Gilead Cleared by U.S. Federal Trade Commission to Close Global Partnership on Filgotinib
Galapagos and Gilead Cleared by U.S. Federal Trade Commission to Close Global Partnership on Filgotinib
HSMN NewsFeed - 17 Dec 2015
Oculus Innovative Sciences Receives FDA Clearance for Microcyn(R)-Based SebDerm Gel
Oculus Innovative Sciences Receives FDA Clearance for Microcyn(R)-Based SebDerm Gel
HSMN NewsFeed - 10 Dec 2015
Lilly and Merck Expand Immuno-Oncology Collaboration Adding Abemaciclib and KEYTRUDA(R) Combination Trial
Lilly and Merck Expand Immuno-Oncology Collaboration Adding Abemaciclib and KEYTRUDA(R) Combination Trial
HSMN NewsFeed - 4 Dec 2015
Samsung Bioepis' RENFLEXIS(R) Infliximab Biosimilar Receives Regulatory Approval in Korea
Samsung Bioepis' RENFLEXIS(R) Infliximab Biosimilar Receives Regulatory Approval in Korea
HSMN NewsFeed - 3 Dec 2015
Mundipharma Establishes an Ophthalmology Business by Acquiring MSD's Portfolio of Glaucoma Products
Mundipharma Establishes an Ophthalmology Business by Acquiring MSD's Portfolio of Glaucoma Products
HSMN NewsFeed - 18 Nov 2015
Moximed Announces CE Mark and First Commercial Use of Atlas(TM) Knee System
Moximed Announces CE Mark and First Commercial Use of Atlas(TM) Knee System
HSMN NewsFeed - 10 Aug 2015
Chiasma Expands Management Team with Announcement of Anand Varadan as Chief Commercial Officer
Chiasma Expands Management Team with Announcement of Anand Varadan as Chief Commercial Officer
HSMN NewsFeed - 15 Jul 2015
Histogenics Corporation Announces Dr. Gloria Matthews as Chief Medical Officer
Histogenics Corporation Announces Dr. Gloria Matthews as Chief Medical Officer
HSMN NewsFeed - 26 Jun 2015
EYLEA(R) (aflibercept) Injection Receives Approval in Japan for the Treatment of Retinal Vein Occlusion
EYLEA(R) (aflibercept) Injection Receives Approval in Japan for the Treatment of Retinal Vein Occlusion
HSMN NewsFeed - 15 Jun 2015
FH Ortho Receives FDA 510(k) Clearance for Its CALCAnail(R) Orthopedic Arthrodesis Nail
FH Ortho Receives FDA 510(k) Clearance for Its CALCAnail(R) Orthopedic Arthrodesis Nail
HSMN NewsFeed - 1 Jun 2015
POZEN Announces Retirement of Founder, Chairman and CEO Dr. John R. Plachetka; Adrian Adams Named as CEO
POZEN Announces Retirement of Founder, Chairman and CEO Dr. John R. Plachetka; Adrian Adams Named as CEO
HSMN NewsFeed - 30 Mar 2015
Horizon Pharma plc to Acquire Hyperion Therapeutics, Inc. for $46.00 per Share or $1.1 Billion in Cash
Horizon Pharma plc to Acquire Hyperion Therapeutics, Inc. for $46.00 per Share or $1.1 Billion in Cash
HSMN NewsFeed - 18 Nov 2014
Antares Pharma Appoints James E. Fickenscher, Senior Vice President, Chief Financial Officer
Antares Pharma Appoints James E. Fickenscher, Senior Vice President, Chief Financial Officer
HSMN NewsFeed - 13 Nov 2014
Nuvo Research(R) reacquires Pennsaid(R) 2% rights to South America, Central America, South Africa and Israel
Nuvo Research(R) reacquires Pennsaid(R) 2% rights to South America, Central America, South Africa and Israel
HSMN NewsFeed - 15 Sep 2014
Antares Pharma Announces Promotion of Robert F. Apple to Chief Operating Officer
Antares Pharma Announces Promotion of Robert F. Apple to Chief Operating Officer
HSMN NewsFeed - 10 Sep 2014
Afferent Pharmaceuticals Names Kathleen Sereda Glaub as Chief Executive Officer
Afferent Pharmaceuticals Names Kathleen Sereda Glaub as Chief Executive Officer
HSMN NewsFeed - 11 Aug 2014
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME)
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME)
HSMN NewsFeed - 10 Jul 2014
Smith & Nephew enters commercial agreement to bring robotic navigation to the JOURNEY UNI Knee procedure
Smith & Nephew enters commercial agreement to bring robotic navigation to the JOURNEY UNI Knee procedure
HSMN NewsFeed - 17 Jun 2014
Wright Medical Group, Inc. Announces Commercial Launch of INFINITY(R) Total Ankle System
Wright Medical Group, Inc. Announces Commercial Launch of INFINITY(R) Total Ankle System
HSMN NewsFeed - 3 Jun 2014
Spinifex Pharmaceuticals Appoints Neuroscience Expert Dr Ronald Marcus as Chief Medical Officer
Spinifex Pharmaceuticals Appoints Neuroscience Expert Dr Ronald Marcus as Chief Medical Officer
HSMN NewsFeed - 27 May 2014
Spinifex Pharmaceuticals Strengthens Scientific Advisory Board (SAB) with Experts in Chronic Pain
Spinifex Pharmaceuticals Strengthens Scientific Advisory Board (SAB) with Experts in Chronic Pain
HSMN NewsFeed - 19 May 2014
Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug Development & Chief Medical Officer
Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug Development & Chief Medical Officer
HSMN NewsFeed - 19 Mar 2014
Horizon Pharma to Acquire Vidara Therapeutics International Ltd. and Become Horizon Pharma plc
Horizon Pharma to Acquire Vidara Therapeutics International Ltd. and Become Horizon Pharma plc
HSMN NewsFeed - 13 Mar 2014
Anika Therapeutics Announces Dismissal of MONOVISC(R) U.S. Patent Infringement Lawsuit
Anika Therapeutics Announces Dismissal of MONOVISC(R) U.S. Patent Infringement Lawsuit
HSMN NewsFeed - 5 Mar 2014
Horizon Pharma Names Robert F. Carey Executive Vice President and Chief Business Officer
Horizon Pharma Names Robert F. Carey Executive Vice President and Chief Business Officer
HSMN NewsFeed - 30 Dec 2013
OphthaliX Announces Top-Line Results of Phase III Study with CF101 for Dry Eye Syndrome
OphthaliX Announces Top-Line Results of Phase III Study with CF101 for Dry Eye Syndrome
HSMN NewsFeed - 23 Dec 2013
Blue Belt Technologies announces first Navio(TM) Unicondylar Knee Replacement performed in France
Blue Belt Technologies announces first Navio(TM) Unicondylar Knee Replacement performed in France
HSMN NewsFeed - 17 Dec 2013
Zogenix Appoints Chief Medical Officer and Expands Medical Leadership Team
Zogenix Appoints Chief Medical Officer and Expands Medical Leadership Team
HSMN NewsFeed - 27 Nov 2013
Sorin Group Announces CE Mark Approval and First Implant of KORA 100, a New MRI Compatible Pacing System
Sorin Group Announces CE Mark Approval and First Implant of KORA 100, a New MRI Compatible Pacing System
HSMN NewsFeed - 19 Nov 2013
Antares Pharma Appoints David H. Bergstrom Ph.D. as Senior Vice President Pharmaceutical Development
Antares Pharma Appoints David H. Bergstrom Ph.D. as Senior Vice President Pharmaceutical Development
HSMN NewsFeed - 19 Nov 2013
Horizon Pharma Announces Agreement to Acquire U.S. Rights to VIMOVO(R) and Provides 2014 Guidance
Horizon Pharma Announces Agreement to Acquire U.S. Rights to VIMOVO(R) and Provides 2014 Guidance
HSMN NewsFeed - 18 Nov 2013
Auxilium Announces Results of the XIAFLEX(R) in Dupuytren's MULTICORD Contracture Trial
Auxilium Announces Results of the XIAFLEX(R) in Dupuytren's MULTICORD Contracture Trial
HSMN NewsFeed - 24 Oct 2013
Celsus Therapeutics Announces Appointment of Pablo Jimenez, M.D., to Chief Medical Officer
Celsus Therapeutics Announces Appointment of Pablo Jimenez, M.D., to Chief Medical Officer
HSMN NewsFeed - 18 Oct 2013
Cimzia(R) (Certolizumab Pegol) Approved by FDA for Treatment of Adults with Active Ankylosing Spondylitis
Cimzia(R) (Certolizumab Pegol) Approved by FDA for Treatment of Adults with Active Ankylosing Spondylitis
HSMN NewsFeed - 8 Oct 2013
Moximed Initiates Study in UK of KineSpring(R) System in Patients with Knee Osteoarthritis
Moximed Initiates Study in UK of KineSpring(R) System in Patients with Knee Osteoarthritis
HSMN NewsFeed - 3 Oct 2013
Aubagio(R) Significantly Reduced Risk of New Clinical Relapse or MRI Lesion in Multiple Sclerosis Study
Aubagio(R) Significantly Reduced Risk of New Clinical Relapse or MRI Lesion in Multiple Sclerosis Study
HSMN NewsFeed - 25 Sep 2013
Stryker Announces Definitive Agreement to Acquire MAKO Surgical Corp. for $1.65 Billion
Stryker Announces Definitive Agreement to Acquire MAKO Surgical Corp. for $1.65 Billion
HSMN NewsFeed - 24 Sep 2013
Solana Surgical Receives FDA Clearance, Launches the FuseFORCE(TM) SuperElastic Fixation System
Solana Surgical Receives FDA Clearance, Launches the FuseFORCE(TM) SuperElastic Fixation System
HSMN NewsFeed - 26 Aug 2013
Introducing New Advil(R) Film Coated Tablets – Designed to Stop Pain Before It Gets Worse
Introducing New Advil(R) Film Coated Tablets – Designed to Stop Pain Before It Gets Worse
HSMN NewsFeed - 22 Aug 2013
Horizon Pharma Announces Settlement of DUEXIS(R) Patent Litigation With Par Pharmaceutical
Horizon Pharma Announces Settlement of DUEXIS(R) Patent Litigation With Par Pharmaceutical
HSMN NewsFeed - 12 Aug 2013
Medtronic Advances Healthcare Services and Solutions Strategy with Acquisition of Cardiocom
Medtronic Advances Healthcare Services and Solutions Strategy with Acquisition of Cardiocom
HSMN NewsFeed - 16 Jul 2013
Ceterix Announces U.S. Launch of Novel Device for Minimally Invasive Orthopaedic Procedures
Ceterix Announces U.S. Launch of Novel Device for Minimally Invasive Orthopaedic Procedures
HSMN NewsFeed - 10 Jul 2013
Idera Pharmaceuticals Appoints James Geraghty as Chairman of the Board of Directors
Idera Pharmaceuticals Appoints James Geraghty as Chairman of the Board of Directors
HSMN NewsFeed - 28 Jun 2013
Genzyme Receives Positive CHMP Opinion for LEMTRADA(TM) (alemtuzumab) in Europe
Genzyme Receives Positive CHMP Opinion for LEMTRADA(TM) (alemtuzumab) in Europe
HSMN NewsFeed - 7 May 2013
Coronado Biosciences Appoints Thomas F. Schaible, Ph.D. as Project Leader, Inflammatory Bowel Disease
Coronado Biosciences Appoints Thomas F. Schaible, Ph.D. as Project Leader, Inflammatory Bowel Disease
HSMN NewsFeed - 29 Apr 2013
UPLYSO(TM) (alfataliglicerase) Approved in Mexico and Chile for the Treatment of Gaucher Disease
UPLYSO(TM) (alfataliglicerase) Approved in Mexico and Chile for the Treatment of Gaucher Disease
HSMN NewsFeed - 15 Apr 2013
Carticept(R) Medical Receives 510(k) Clearance for Second Generation Navigator(R) Delivery System
Carticept(R) Medical Receives 510(k) Clearance for Second Generation Navigator(R) Delivery System
HSMN NewsFeed - 11 Apr 2013
BD Announces FDA 510(k) Clearance and Commercial Launch of BD UltraSafe PLUS(TM) Passive Needle Guard
BD Announces FDA 510(k) Clearance and Commercial Launch of BD UltraSafe PLUS(TM) Passive Needle Guard
HSMN NewsFeed - 5 Feb 2013
FDA Clears Sculptor Robotic Guidance Arm(TM) for Unicompartmental Knee Replacement Surgery
FDA Clears Sculptor Robotic Guidance Arm(TM) for Unicompartmental Knee Replacement Surgery
HSMN NewsFeed - 29 Jan 2013
Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
HSMN NewsFeed - 28 Jan 2013
Genzyme’s LEMTRADA(TM) (alemtuzumab) Application for MS Accepted for Review by the FDA
Genzyme’s LEMTRADA(TM) (alemtuzumab) Application for MS Accepted for Review by the FDA
HSMN NewsFeed - 17 Dec 2012
Lexicon's Drug Candidate For Irritable Bowel Syndrome Receives Fast Track Status From The FDA
Lexicon's Drug Candidate For Irritable Bowel Syndrome Receives Fast Track Status From The FDA
HSMN NewsFeed - 27 Nov 2012
Carbylan Biosurgery, Inc. and Shanghai Jingfeng Pharmaceutical Corporation Announce License Agreement
Carbylan Biosurgery, Inc. and Shanghai Jingfeng Pharmaceutical Corporation Announce License Agreement
HSMN NewsFeed - 13 Nov 2012
Antares Pharma Announces Positive Results from Final MTX Medi-Jet(TM) Clinical Study
Antares Pharma Announces Positive Results from Final MTX Medi-Jet(TM) Clinical Study
HSMN NewsFeed - 1 Nov 2012
BioTime Subsidiary OrthoCyte Corporation Announces the Appointment of Francois Binette as Vice President
BioTime Subsidiary OrthoCyte Corporation Announces the Appointment of Francois Binette as Vice President
HSMN NewsFeed - 19 Oct 2012
Savient Receives Positive CHMP Opinion for KRYSTEXXA(R) Approval in the EU
Savient Receives Positive CHMP Opinion for KRYSTEXXA(R) Approval in the EU
HSMN NewsFeed - 16 Oct 2012
BioAdvance Expands Team to Support Portfolio Companies and New Investments
BioAdvance Expands Team to Support Portfolio Companies and New Investments
HSMN NewsFeed - 12 Oct 2012
Amgen Appoints Cynthia Patton Senior Vice President And Chief Compliance Officer
Amgen Appoints Cynthia Patton Senior Vice President And Chief Compliance Officer
HSMN NewsFeed - 11 Oct 2012
Pfizer Announces Top-Line Results From A Phase 3 Long-Term Safety Study Of ALO-02:
Pfizer Announces Top-Line Results From A Phase 3 Long-Term Safety Study Of ALO-02:
HSMN NewsFeed - 28 Sep 2012
PTC Therapeutics Appoints Jerome B. Zeldis, M.D., Ph.D. to Board of Directors
PTC Therapeutics Appoints Jerome B. Zeldis, M.D., Ph.D. to Board of Directors
HSMN NewsFeed - 4 Sep 2012
Vertex Announces Appointment of Stuart A. Arbuckle as Chief Commercial Officer
Vertex Announces Appointment of Stuart A. Arbuckle as Chief Commercial Officer
HSMN NewsFeed - 31 Jul 2012
Prometheus Launches New Monitoring Test To Help Guide Inflammatory Bowel Disease Management
Prometheus Launches New Monitoring Test To Help Guide Inflammatory Bowel Disease Management
HSMN NewsFeed - 19 Jun 2012
AstraZeneca And Rigel Sign Worldwide License Agreement For A Potential New Treatment For Chronic Asthma
AstraZeneca And Rigel Sign Worldwide License Agreement For A Potential New Treatment For Chronic Asthma
HSMN NewsFeed - 7 May 2012
New Biologics Company, Bioventus, Launches with Focus on Active Orthopaedic Healing
New Biologics Company, Bioventus, Launches with Focus on Active Orthopaedic Healing
HSMN NewsFeed - 3 May 2012
Genentech Reports Positive Study of ACTEMRA Given by Subcutaneous Injection
Genentech Reports Positive Study of ACTEMRA Given by Subcutaneous Injection
HSMN NewsFeed - 25 Apr 2012
Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
HSMN NewsFeed - 22 Mar 2012
Integra LifeSciences Launches New Shoulder Arthroplasty Device in Italy and Sweden
Integra LifeSciences Launches New Shoulder Arthroplasty Device in Italy and Sweden
HSMN NewsFeed - 7 Feb 2012
Ligand Names Nishan de Silva, M.D., Vice President of Corporate Development
Ligand Names Nishan de Silva, M.D., Vice President of Corporate Development
HSMN NewsFeed - 30 Jan 2012
ConforMIS Reaches Funding Milestone with $89 Million in Series E Financing
ConforMIS Reaches Funding Milestone with $89 Million in Series E Financing
HSMN NewsFeed - 20 Jan 2012
La Jolla Pharmaceutical Company Acquires GCS-100, a First-in-Class Galectin-3 Antagonist
La Jolla Pharmaceutical Company Acquires GCS-100, a First-in-Class Galectin-3 Antagonist
HSMN NewsFeed - 6 Jan 2012
Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA(R)
Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA(R)
HSMN NewsFeed - 6 Dec 2011
Amgen and FDA Agree to Modify Nplate(R) (Romiplostim) Risk Evaluation and Mitigation Strategy
Amgen and FDA Agree to Modify Nplate(R) (Romiplostim) Risk Evaluation and Mitigation Strategy
HSMN NewsFeed - 8 Nov 2011
Abbott Reports Five-Year Data for HUMIRA(R) (Adalimumab) in Ankylosing Spondylitis
Abbott Reports Five-Year Data for HUMIRA(R) (Adalimumab) in Ankylosing Spondylitis
HSMN NewsFeed - 10 Oct 2011
Ligand Enters Into Global Licensing Agreement With Chiva Pharmaceuticals for Fablyn(R)
Ligand Enters Into Global Licensing Agreement With Chiva Pharmaceuticals for Fablyn(R)
HSMN NewsFeed - 20 Sep 2011
Exactech Introduces New Material, Efficient Approach for Acetabular Reconstruction
Exactech Introduces New Material, Efficient Approach for Acetabular Reconstruction
HSMN NewsFeed - 13 Sep 2011
Stellar Pharmaceuticals Receives European Approval for NeoVisc(R) Single Dose
Stellar Pharmaceuticals Receives European Approval for NeoVisc(R) Single Dose
Additional items found! 500

Members Archive contains
500 additional stories matching:
arthritis
(Password required)
arthritis
(Password required)